Effect of siRNA against β-NGF on nerve fibers of a rat model with endometriosis

Reproductive Sciences

Volumn 21, Issue 3, 2014, Pages 329-339

  Chen, Yan ^a   Li, Dong ^a   Zhang, Zhe ^a   Takushige, Natsuko ^b   Kong, Bei Hua ^a   Wang, Guo Yun ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

endometriosis; immunohistochemistry; nerve fibers; nerve growth factor; siRNA

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NERVE GROWTH FACTOR BETA SUBUNIT; NERVE GROWTH FACTOR RECEPTOR; NEUROMODULIN; NEUROPEPTIDE Y; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE SILENCING; GENE TRANSFER; HYPERALGESIA; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE; SYMPATHETIC INNERVATION; TAIL FLICK TEST;

ENDOMETRIOSIS; IMMUNOHISTOCHEMISTRY; NERVE FIBERS; NERVE GROWTH FACTOR; SIRNA;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; GENE SILENCING; GENETIC THERAPY; MCF-7 CELLS; NERVE FIBERS; NERVE GROWTH FACTOR; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; TREATMENT OUTCOME;

EID: 84896893130     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113497279     Document Type: Article

References (57)

1. Vercellini P, De Giorgi O, Pisacreta A, Pesole AP, Vicentini S, Crosignani PG. Surgical management of endometriosis. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14 (3). 501-523
2. Candiani GB, Fedele L, Vercellini P, Bianchi S, Di Nola G. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991; 77 (3). 421-424
3. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991; 56 (1). 45-51
4. Koninckx PR, Kennedy SH, Barlow DH. Pathogenesis of endometriosis: the role of peritoneal fluid. Gynecol Obstet Invest. 1999; 47 (suppl 1). 23-33
5. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 1997; 121 (3). 417-424
6. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995; 63 (3). 289-302
7. Anaf V, Simon P, El Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000; 15 (8). 1744-1750
8. Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science. 2005; 308 (5728). 1587-1589
9. Tokushige N, Markham R, Russell P, Fraser IS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod. 2006; 21 (3). 782-787
10. Farinas I. Neurotrophin actions during the development of the peripheral nervous system. Microsc Res Tech. 1999; 45 (4-5). 233-242
11. Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA. 1999; 96 (14). 7693-7696
12. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci. 1996; 351 (1338). 441-448
13. Gee AP, Boyle MD, Munger KL, Lawman MJ, Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA. 1983; 80 (23). 7215-7218
14. Dyck PJ, Peroutka S, Rask C, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology. 1997; 48 (2). 501-505
15. Delafoy L, Raymond F, Doherty AM, Eschalier A, Diop L. Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity. Pain. 2003; 105 (3). 489-497
16. Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005; 115 (1-2). 128-141
17. Campbell TN, Choy FY. RNA interference: past, present and future. Curr Issues Mol Biol. 2005; 7 (1). 1-6
18. Perrimon N, Ni JQ, Perkins L. In vivo RNAi: today and tomorrow. Cold Spring Harb Perspect Biol. 2010; 2 (8). a003640
19. Karagiannis TC, El-Osta A. siRNAs: mechanism of RNA interference, in vivo and potential clinical applications. Cancer Biol Ther. 2004; 3 (11). 1069-1074
20. Hannon GJ. RNA interference. Nature. 2002; 418 (6894). 244-251
21. Bi F, Liu N, Fan D. Small interfering RNA: a new tool for gene therapy. Curr Gene Ther. 2003; 3 (5). 411-417
22. Tamburro S, Canis M, Albuisson E, Dechelotte P, Darcha C, Mage G. Expression of transforming growth factor beta1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril. 2003; 80 (5). 1131-1136
23. Tokushige N, Markham R, Russell P, Fraser IS. Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril. 2007; 88 (4). 795-803
24. Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006; 21 (11). 3001-3007
25. Berkley KJ, Dmitrieva N, Curtis KS, Papka RE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA. 2004; 101 (30). 11094-11098
26. Wang G, Tokushige N, Markham R, Fraser IS. Rich innervation of deep infiltrating endometriosis. Hum Reprod. 2009; 24 (4). 827-834
27. Dolle L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 2003; 22 (36). 5592-5601
28. Adriaenssens E, Vanhecke E, Saule P, et al. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008; 68 (2). 346-351
29. Zulfikaroglu E, Kilic S, Islimye M, Aydin M, Zergeroglu S, Batioglu S. Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet. 2011; 283 (4). 799-804
30. Lashbrook JM, Ossipov MH, Hunter JC, Raffa RB, Tallarida RJ, Porreca F. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1-and COX2-inhibitors in nerve-injured rats. Pain. 1999; 82 (1). 65-72
31. Jones BG, Dickinson PA, Gumbleton M, Kellaway IW. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. Int J Pharm. 2002; 236 (1-2). 65-79
32. Berkley KJ, Cason A, Jacobs H, Bradshaw H, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001; 306 (3). 185-188
33. Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010; 25 (4). 1014-1025
34. He W, Liu X, Zhang Y, Guo SW. Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery. Reprod Sci. 2010; 17 (12). 1099-1111
35. Cason AM, Samuelsen CL, Berkley KJ. Estrous changes in vaginal nociception in a rat model of endometriosis. Horm Behav. 2003; 44 (2). 123-131
36. Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol. 2009; 16 (5). 540-550
37. McAllister SL, Dmitrieva N, Berkley KJ. Sprouted innervation into uterine transplants contributes to the development of hyperalgesia in a rat model of endometriosis. PLoS One. 2012; 7 (2). e31758
38. Apfel SC. Neurotrophic factors and pain. Clin J Pain. 2000; 16 (suppl 2). S7-S11
39. Kessler JA, Black IB. Nerve growth factor stimulates the development of substance P in sensory ganglia. Proc Natl Acad Sci USA. 1980; 77 (1). 649-652
40. Davis BM, Lewin GR, Mendell LM, Jones ME, Albers KM. Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neuroscience. 1993; 56 (4). 789-792
41. Rueff A, Mendell LM. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol. 1996; 76 (5). 3593-3596
42. Hill RG, Oliver KR. Neuropeptide and kinin antagonists. Handb Exp Pharmacol. 2007; 177: 181-216
43. Zhang G, Dmitrieva N, Liu Y, McGinty KA, Berkley KJ. Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat. Am J Physiol Regul Integr Comp Physiol. 2008; 294 (1). R162-R171
44. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002; 59 (4). 603-608
45. Freemont AJ, Watkins A, Le Maitre C, et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002; 197 (3). 286-292
46. Michael GJ, Priestley JV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci. 1999; 19 (5). 1844-1854
47. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000; 10 (3). 381-391
48. Averill S, Delcroix JD, Michael GJ, Tomlinson DR, Fernyhough P, Priestley JV. Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci. 2001; 18 (2). 183-196
49. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999; 2 (12). 1114-1119
50. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA. 1999; 96 (14). 7723-7730
51. Wright DE, Snider WD. Neurotrophin receptor mRNA expression defines distinct populations of neurons in rat dorsal root ganglia. J Comp Neurol. 1995; 351 (3). 329-338
52. Barcena de Arellano ML, Arnold J, Vercellino F, Chiantera V, Schneider A, Mechsner S. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil Steril. 2011; 95 (3). 1123-1126
53. Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain. 2005; 116 (1-2). 8-16
54. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003; 5 (9). 834-839
55. Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 2005; 11 (3). 263-270
56. Morrissey DV, Lockridge JA, Shaw L, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol. 2005; 23 (8). 1002-1007
57. Marques JT, Williams BR. Activation of the mammalian immune system by siRNAs. Nat Biotechnol. 2005; 23 (11). 1399-1405